ユタにおける前立腺がんの臨床試験
ユタ内の拠点で、前立腺がんに関する24件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Intermountain Medical Center, Murray
- McKay-Dee Hospital Center, Ogden
- LDS Hospital, Salt Lake City
- 他2件
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT06931340A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
- Huntsman Cancer Institute and Hospital, Salt Lake City
被験者募集中第2相
18歳以上 · 男性 · 2026/09/30更新 · NCT05534646A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 男性 · 2026/09/25更新 · NCT07746713This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第3相
18歳以上 · 男性 · 2026/09/24更新 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Utah Intermountain Medical Center, Murray
被験者募集中第2/3相
18歳〜100歳 · 男性 · 2026/09/22更新 · NCT06780670First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, West Valley City
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/16更新 · NCT07332455Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Intermountain Health, Murray
被験者募集中第3相
18歳以上 · 男性 · 2026/09/11更新 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork
- Sandra L Maxwell Cancer Center, Cedar City
- Farmington Health Center, Farmington
- 他9件
被験者募集中第3相
18歳以上 · 男性 · 2026/09/10更新 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Summit Urology, Murray
被験者募集中第3相
18歳以上 · 男性 · 2026/09/03更新 · NCT07723248AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Salt Lake City
被験者募集中第3相
18歳以上 · 男性 · 2026/08/26更新 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- START Mountain Region, West Valley City
被験者募集中第2相
18歳以上 · 男性 · 2026/08/24更新 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Intermountain Medical Center, Murray
被験者募集中第1相
18歳以上 · 男性 · 2026/08/21更新 · NCT04221542Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT05413421Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT07517198Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第2相
18歳以上 · 男性 · 2026/06/05更新 · NCT05168618Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第3相
18歳以上 · 男性 · 2026/06/03更新 · NCT06112990Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
- Huntsman Cancer Institute at University of Utah, Salt Lake City
被験者募集中
18歳以上 · 男性 · 2026/04/13更新 · NCT07093177A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT07145255SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
被験者募集中第3相
18歳以上 · 男性 · 2025/09/11更新 · NCT03678025Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
- University of Utah Huntsman Cancer Institute, Salt Lake City
被験者募集中
21歳以上 · 男性 · 2025/08/01更新 · NCT07032584ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。